Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Haemonetics (HAE) Amortization of Deferred Charges (2020 - 2024)

Haemonetics has reported Amortization of Deferred Charges over the past 9 years, most recently at $782000.0 for Q1 2024.

  • For Q1 2024, Amortization of Deferred Charges fell 10.32% year-over-year to $782000.0; the TTM value through Mar 2024 reached $3.2 million, up 61.17%, while the annual FY2024 figure was $3.2 million, 61.17% up from the prior year.
  • Amortization of Deferred Charges for Q1 2024 was $782000.0 at Haemonetics, roughly flat from $783000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $1.0 million in Q3 2021 and troughed at -$484000.0 in Q4 2022.
  • A 5-year average of $630500.0 and a median of $789500.0 in 2021 define the central range for Amortization of Deferred Charges.
  • On a YoY basis, Amortization of Deferred Charges climbed as much as 472.66% in 2022 and fell as far as 160.96% in 2022.
  • Year by year, Amortization of Deferred Charges stood at $139000.0 in 2020, then skyrocketed by 471.22% to $794000.0 in 2021, then dropped by 1.13% to $785000.0 in 2022, then dropped by 0.25% to $783000.0 in 2023, then decreased by 0.13% to $782000.0 in 2024.
  • Business Quant data shows Amortization of Deferred Charges for HAE at $782000.0 in Q1 2024, $783000.0 in Q4 2023, and $780000.0 in Q3 2023.